Extracellular Matrix: A Matter of Life and Death

REFERENCES

• Li H., Fan X., Houghton J.M. Tumor microenvironment:the role of the tumor stroma in cancer. J. Cell. Biochem. 2007; 101: 805–815
   PubMed Web of Science ®Google Scholar
• Gilmore A.P. Anoikis. Cell Death Differentiation 2005; 12: 1473–1477
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson W.G. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am. J. Pathol. 1996; 148: 1345–1350
   PubMed Web of Science ®Google Scholar
• Bissell M.J., Radisky D. Putting tumors in context. Nat. Rev. Cancer. 2001; 1(1)46–54
   PubMed Web of Science ®Google Scholar
• Bornstein P., Sage H. Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell Biol. 2002; 14: 608–616
   PubMed Web of Science ®Google Scholar
• Mongiat M., Ligresti G., Marastoni S., Lorenzon E., Doliana R., Colombatti A. Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2. Mol. Cell. Biol. 2007; 27(20)7176–7187
   PubMed Web of Science ®Google Scholar
• Larsen M., Artym V.V., Green J.A., Yamada K.M. The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr. Opin. Cell Biol. 2006; 18(5)463–471
   PubMed Web of Science ®Google Scholar
• Guo W., Giancotti F.G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 2004; 5(10)816–826
   PubMed Web of Science ®Google Scholar
• Frish S.M., Scraton R.A. Anoikis mechanism. Curr. Opin. Cell Biol. 2001; 13: 555–562
   PubMed Web of Science ®Google Scholar
• Tlsty T.D. Stromal cells can contribute oncogenic signals. Semin. Cancer Biol. 2001; 11(2)97–104
   PubMed Web of Science ®Google Scholar
• Pupa S.M., Ménard S., Forti S., Tagliabue E. New insights into the role of extracellular matrix durin tumor onset and progression. J. Cell. Physiol. 2002; 192(3)259–267
   PubMed Web of Science ®Google Scholar
• Sethi T., Rintoul R.C., Moore S.M., Mackinnon A.C., Salter D., Choo C., Chilvers E.R., Dransfield I., Donnelly S.C., Strieter R., Haslett C. Extracellular matrix proteins protect small cell lung cancer against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 1999; 5(6)662–668
   PubMed Web of Science ®Google Scholar
• Han S.W., Khuri F.R., Roman J. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer Res 2006; 66(1)315–322
   PubMed Web of Science ®Google Scholar
• Gu J., Fujibayashi A., Yamada K.M., Sekiguchi K. Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via phosphatidylinositol 3-kinase/Akt- and MEK1/ERK-dependent pathways. J. Biol. Chem. 2002; 277(22)19922–19928
   PubMed Web of Science ®Google Scholar
• Kaspar M., Zardi L., Neri D. Fibronectin as target for tumor therapy. Int. J. Cancer. 2007; 118: 1331–1339
   Web of Science ®Google Scholar
• Camoglio P.M., Tuscolino L. Cancer: the matrix is now in control. Nat. Med. 2005; 11(11)1156–1159
   PubMed Web of Science ®Google Scholar
• Huang S., Ingber D.E. Cell tension, matrix mechanics, and cancer development. Cancer Cell. 2005; 8(3)175–176
   PubMed Web of Science ®Google Scholar
• Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., Reinhart-King C.A., Margulies S.S., Dembo M., Boettiger D., Hammer D.A., Weaver V.M. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005; 8(3)241–254
   PubMed Web of Science ®Google Scholar
• Todorovic V., Chen C.C., Hay N., Lau L.F. The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J. Cell. Biol. 2005; 171(3)559–568
   PubMed Web of Science ®Google Scholar
• Jimenez B., Volpert O.V., Crawford S.E., Febbraio M., Silverstein R.L., Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 2000; 6(1)41–48
   PubMed Web of Science ®Google Scholar
• Dawson D.W., Pearce S.F., Zhong R., Silverstein R.L., Frazier W.A., Bouck N.P. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell. Biol. 1997; 138(3)707–17
   PubMed Web of Science ®Google Scholar
• Shichiri M., Hirata Y. Antiangiogenesis signals by endostatin. FASEB J 2001; 15(6)1044–53
   PubMed Web of Science ®Google Scholar
• Wickstrom S.A., Alitalo K., Keski-Oja J. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J. Biol. Chem. 2003; 278(39)37895–37901
   PubMed Web of Science ®Google Scholar
• Hanai J., Dhanabal M., Karumanchi S.A., Albanese C., Waterman M., Chan B., Ramchandran R., Pestell R., Sukhatme V.P. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J. Biol. Chem. 2002; 277(19)16464–16469
   PubMed Web of Science ®Google Scholar
• Puolakkainen P.A., Brekken R.A., Muneer S., Sage E.H. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. Mol Cancer Res. 2004; 2(4)215–224
   PubMed Web of Science ®Google Scholar
• Seidler D.G., Goldoni S., Agnew C., Cardi C., Thakur M.L., Owens R.T., McQuillan D.J., Iozzo R.V. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J. Biol. Chem. 2006; 281(36)26408–24618
   PubMed Web of Science ®Google Scholar